Skip to main content

Advertisement

Log in

An APP mutation family exhibiting white matter hyperintensities and cortical calcification in East China

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Heterozygous amyloid precursor protein (APP) mutations cause hereditary cerebral amyloid angiopathy (CAA) and autosomal dominant Alzheimer’s disease (AD). This study aimed at reporting an APP mutation and its associated clinical and neuroimaging features. The proband and her family members presented with memory loss, psychiatric, and visual symptoms. Neuroimaging revealed bilateral white matter intensities (WMH) in cranial magnetic resonance imaging (MRI), cortical calcification, and brain atrophy. Next-generation sequencing-based comprehensive gene panel revealed heterozygous missense variant c.2059A>C (p.K687Q) mutation in the APP gene. Co-segregation analysis identified seven family members to be APP mutation carriers while normal neuroimaging features were seen in all family members lacking the APP mutation. WMH and cortical calcification were observed in patients with CAA, including those with the Iowa (D694N) and Italian (E693K) mutations. Further studies should investigate the functional changes associated with the heterozygous APP mutation (K687Q).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Li NM, Liu KF, Qiu YJ, Zhang HH, Nakanishi H, Qing H (2019) Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer’s disease pathogenesis. Neural Regen Res 14(4):658–665. https://doi.org/10.4103/1673-5374.247469

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bugiani O (2019) The puzzle of preserved cognition in the oldest old. Neurol Sci 41:441–447. https://doi.org/10.1007/s10072-019-04111-y

    Article  PubMed  Google Scholar 

  3. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118(1):115–130. https://doi.org/10.1007/s00401-009-0501-

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hunter S, Brayne C (2018) Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. Mol Psychiatry 23(1):81–93. https://doi.org/10.1038/mp.2017.218

    Article  CAS  PubMed  Google Scholar 

  5. Guardia-Laguarta C, Pera M, Clarimon J, Molinuevo JL, Sanchez-Valle R, Llado A, Coma M, Gomez-Isla T, Blesa R, Ferrer I, Lleo A (2010) Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol 69(1):53–59. https://doi.org/10.1097/NEN.0b013e3181c6b84d

    Article  CAS  PubMed  Google Scholar 

  6. Rossi G, Giaccone G, Maletta R, Morbin M, Capobianco R, Mangieri M, Giovagnoli AR, Bizzi A, Tomaino C, Perri M, Di Natale M, Tagliavini F, Bugiani O, Bruni AC (2004) A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology 63(5):910–912

    Article  CAS  Google Scholar 

  7. Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R, Morbin M, Mazzoleni G, Cupidi C, Marcon G, Giovagnoli A, Bizzi A, Di Fede G, Puoti G, Carella F, Salmaggi A, Romorini A, Patruno GM, Magoni M, Padovani A, Tagliavini F (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67(8):987–995. https://doi.org/10.1001/archneurol.2010.178

    Article  PubMed  Google Scholar 

  8. Iwanowski P, Kozubski W, Losy J (2015) Iowa-type hereditary cerebral amyloid angiopathy in a Polish family. J Neurol Sci 356(1–2):202–204. https://doi.org/10.1016/j.jns.2015.06.020

    Article  PubMed  Google Scholar 

  9. Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49(6):697–705. https://doi.org/10.1002/ana.1009

    Article  CAS  PubMed  Google Scholar 

  10. Greenberg SM, Shin Y, Grabowski TJ, Cooper GE, Rebeck GW, Iglesias S, Chapon F, Tournier-Lasserve E, Baron J-C (2003) Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology 60(6):1020–1022. https://doi.org/10.1212/01.WNL.0000050140.10044.A8

    Article  CAS  PubMed  Google Scholar 

  11. Iglesias S, Chapon F, Baron J-C (2000) Familial occipital calcifications, hemorrhagic strokes, leukoencephalopathy, dementia, and external carotid dysplasia. Neurology 55(11):1661–1667. https://doi.org/10.1212/WNL.55.11.1661

    Article  CAS  PubMed  Google Scholar 

  12. Mok T, Chalissery AJ, Byrne S, Costelloe L, Galvin L, Vinters HV, Farrell MA, Brett FM, Moroney JT (2014) Familial cerebral amyloid angiopathy due to the Iowa mutation in an Irish family. Can J Neurol Sci 41(04):512–517. https://doi.org/10.1017/S031716710001859X

    Article  PubMed  Google Scholar 

  13. Zarranz JJ, Fernandez-Martinez M, Rodriguez O, Mateos B, Iglesias S, Baron J-C (2016) Iowa APP mutation-related hereditary cerebral amyloid angiopathy (CAA): a new family from Spain. J Neurol Sci 363:55–56. https://doi.org/10.1016/j.jns.2016.02.029

    Article  CAS  PubMed  Google Scholar 

  14. Sellal F, Wallon D, Martinez-Almoyna L, Marelli C, Dhar A, Oesterlé H, Rovelet-Lecrux A, Rousseau S, Kourkoulis CE, Rosand J, DiPucchio ZY, Frosch M, Gombert C, Audoin B, Miné M, Riant F, Frebourg T, Hannequin D, Campion D, Greenberg SM, Tournier-Lasserve E, Nicolas G (2017) APP mutations in cerebral amyloid angiopathy with or without cortical calcifications: report of three families and a literature review. J Alzheimers Dis 56(1):37–46. https://doi.org/10.3233/JAD-160709

    Article  PubMed  Google Scholar 

  15. Li H, Jia J, Yang Z (2016) Mini-mental state examination in elderly Chinese: a population-based normative study. J Alzheimers Dis 53(2):487–496. https://doi.org/10.3233/JAD-160119

    Article  PubMed  Google Scholar 

  16. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x

    Article  PubMed  Google Scholar 

  17. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A (2000) The mini-cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 15(11):1021–1027. https://doi.org/10.1002/1099-1166(200011)15:11<1021::aid-gps234>3.0.co;2-6

    Article  CAS  PubMed  Google Scholar 

  18. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78(11):803–810. https://doi.org/10.1212/WNL.0b013e318249f71f

    Article  CAS  PubMed  Google Scholar 

  19. Jiang B, Zhou J, Li HL, Chen YG, Cheng HR, Ye LQ, Liu DS, Chen DF, Tao QQ, Wu ZY (2019) Mutation screening in Chinese patients with familial Alzheimer’s disease by whole-exome sequencing. Neurobiol Aging 76:215 e215–215 e221. https://doi.org/10.1016/j.neurobiolaging.2018.11.024

    Article  CAS  Google Scholar 

  20. Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TLS, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Förster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM, Network DIA (2016) White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol 79(6):929–939. https://doi.org/10.1002/ana.24647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP (2018) White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer’s disease: a domain-specific meta-analysis. J Alzheimers Dis 63(2):515–527. https://doi.org/10.3233/JAD-170573

    Article  PubMed  Google Scholar 

  22. Thanprasertsuk S, Martinez-Ramirez S, Pontes-Neto OM, Ni J, Ayres A, Reed A, Swords K, Gurol ME, Greenberg SM, Viswanathan A (2014) Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology 83(9):794–800. https://doi.org/10.1212/WNL.0000000000000732

    Article  PubMed  PubMed Central  Google Scholar 

  23. Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M, Team BR (2019) White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology. https://doi.org/10.1212/WNL.0000000000008864

  24. Vinters HV, Natté R, Maat-Schieman MLC, van Duinen SG, Hegeman-Kleinn I, Welling-Graafland C, Haan J, Roos RAC (1998) Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 95(3):235–244. https://doi.org/10.1007/s004010050793

    Article  CAS  PubMed  Google Scholar 

  25. Jellinger KA, Lauda F, Attems J (2007) Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol 14(8):923–928. https://doi.org/10.1111/j.1468-1331.2007.01880.x

    Article  CAS  PubMed  Google Scholar 

  26. Piers RJ (2018) Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan. Neural Regen Res 13(8):1309–1312. https://doi.org/10.4103/1673-5374.235408

    Article  PubMed  PubMed Central  Google Scholar 

  27. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN (1996) Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol 148(6):2083–2095

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank the patients and their family members for participation in this project.

Contributors

Dr. Yang Yi and Dr. Cai Huaying performed the study design and data analysis, wrote and edited the manuscript. Dr. Chen Hui and Dr. Zhong Yufa collected the data. Dr. Ye Xiaobin did literature research. Dr. Zhang Qiaowei and Dr. Hu Xingyue contributed to the study design, data analysis, and editing of the manuscript. All authors read and approved the final manuscript.

Funding

This study was funded in part by the National Natural Science Foundation of China (Proj. Nos. 81601101, 81400926), the Health General Research Project of Zhejiang Province, China (grant numbers 2018244847, 2018RC045) and the Natural Science Foundation of Zhejiang Province of China (LY19H090027).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hu Xingyue or Cai Huaying.

Ethics declarations

This study was approved by the Research Ethics Committees of the participating institute. All patients and their family members provided written informed consent for their participation in this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 27.5 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yi, Y., Xiaobin, Y., Hui, C. et al. An APP mutation family exhibiting white matter hyperintensities and cortical calcification in East China. Neurol Sci 41, 2921–2928 (2020). https://doi.org/10.1007/s10072-020-04342-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04342-4

Keywords

Navigation